Parmaceutical
Use of one or more prenylation inhibitors, cholesterol biosynthesis inhibitors or HMG-CoA reductase inhibitors in the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection. The invention also encompasses a pharmaceutical composition for use in the treatment of HCV infect...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PERROS MANOUSSOS LAXTON CARL JENKINS TIM AHOLA TERO MURRAY TED PARKINSON TANYA |
| description | Use of one or more prenylation inhibitors, cholesterol biosynthesis inhibitors or HMG-CoA reductase inhibitors in the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection. The invention also encompasses a pharmaceutical composition for use in the treatment of HCV infection, the pharmaceutical composition comprising one or more agents capable of inhibiting prenylation, cholesterol biosynthesis or HMG-CoA reductase in the liver, wherein the one or more agents is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2005085528A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2005085528A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2005085528A13</originalsourceid><addsrcrecordid>eNrjZOANSCzKTUxOLS3JTE7M4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFQIV5qSXxocFGBgamBhampkYWjobGxKkCALddHyk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Parmaceutical</title><source>esp@cenet</source><creator>PERROS MANOUSSOS ; LAXTON CARL ; JENKINS TIM ; AHOLA TERO ; MURRAY TED ; PARKINSON TANYA</creator><creatorcontrib>PERROS MANOUSSOS ; LAXTON CARL ; JENKINS TIM ; AHOLA TERO ; MURRAY TED ; PARKINSON TANYA</creatorcontrib><description>Use of one or more prenylation inhibitors, cholesterol biosynthesis inhibitors or HMG-CoA reductase inhibitors in the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection. The invention also encompasses a pharmaceutical composition for use in the treatment of HCV infection, the pharmaceutical composition comprising one or more agents capable of inhibiting prenylation, cholesterol biosynthesis or HMG-CoA reductase in the liver, wherein the one or more agents is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050421&DB=EPODOC&CC=US&NR=2005085528A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050421&DB=EPODOC&CC=US&NR=2005085528A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PERROS MANOUSSOS</creatorcontrib><creatorcontrib>LAXTON CARL</creatorcontrib><creatorcontrib>JENKINS TIM</creatorcontrib><creatorcontrib>AHOLA TERO</creatorcontrib><creatorcontrib>MURRAY TED</creatorcontrib><creatorcontrib>PARKINSON TANYA</creatorcontrib><title>Parmaceutical</title><description>Use of one or more prenylation inhibitors, cholesterol biosynthesis inhibitors or HMG-CoA reductase inhibitors in the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection. The invention also encompasses a pharmaceutical composition for use in the treatment of HCV infection, the pharmaceutical composition comprising one or more agents capable of inhibiting prenylation, cholesterol biosynthesis or HMG-CoA reductase in the liver, wherein the one or more agents is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOANSCzKTUxOLS3JTE7M4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFQIV5qSXxocFGBgamBhampkYWjobGxKkCALddHyk</recordid><startdate>20050421</startdate><enddate>20050421</enddate><creator>PERROS MANOUSSOS</creator><creator>LAXTON CARL</creator><creator>JENKINS TIM</creator><creator>AHOLA TERO</creator><creator>MURRAY TED</creator><creator>PARKINSON TANYA</creator><scope>EVB</scope></search><sort><creationdate>20050421</creationdate><title>Parmaceutical</title><author>PERROS MANOUSSOS ; LAXTON CARL ; JENKINS TIM ; AHOLA TERO ; MURRAY TED ; PARKINSON TANYA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2005085528A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PERROS MANOUSSOS</creatorcontrib><creatorcontrib>LAXTON CARL</creatorcontrib><creatorcontrib>JENKINS TIM</creatorcontrib><creatorcontrib>AHOLA TERO</creatorcontrib><creatorcontrib>MURRAY TED</creatorcontrib><creatorcontrib>PARKINSON TANYA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PERROS MANOUSSOS</au><au>LAXTON CARL</au><au>JENKINS TIM</au><au>AHOLA TERO</au><au>MURRAY TED</au><au>PARKINSON TANYA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Parmaceutical</title><date>2005-04-21</date><risdate>2005</risdate><abstract>Use of one or more prenylation inhibitors, cholesterol biosynthesis inhibitors or HMG-CoA reductase inhibitors in the manufacture of a medicament for the treatment of hepatitis C virus (HCV) infection. The invention also encompasses a pharmaceutical composition for use in the treatment of HCV infection, the pharmaceutical composition comprising one or more agents capable of inhibiting prenylation, cholesterol biosynthesis or HMG-CoA reductase in the liver, wherein the one or more agents is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2005085528A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Parmaceutical |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T18%3A12%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PERROS%20MANOUSSOS&rft.date=2005-04-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2005085528A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |